Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZTI
876
The Marzetti Company Common Stock
MZTI
$5B
| $51.9M | 0.01% |
334,975
+18,057
| +6% | +$2.8M |
|
877
Emergent Biosolutions
EBS
$421M
| $51.8M | 0.01% |
654,665
+13,373
| +2% | +$1.06M |
|
878
Hanover Insurance
THG
$6.29B
| $51.8M | 0.01% |
510,762
-28,792
| -5% | -$2.92M |
|
879
Strategic Education
STRA
$1.97B
| $51.5M | 0.01% |
335,050
+16,998
| +5% | +$2.61M |
|
880
Verint Systems
VRNT
$1.22B
| $51.4M | 0.01% |
2,231,739
+46,070
| +2% | +$1.06M |
|
881
FibroGen
FGEN
$45.6M
| $51.4M | 0.01% |
50,689
+2,804
| +6% | +$2.84M |
|
882
Halozyme
HALO
$8.84B
| $51.2M | 0.01% |
1,910,341
+26,833
| +1% | +$719K |
|
883
LXP Industrial Trust
LXP
$2.76B
| $51.1M | 0.01% |
4,844,367
+1,424,734
| +42% | +$15M |
|
884
Kinsale Capital Group
KNSL
$10.1B
| $51.1M | 0.01% |
329,138
+26,148
| +9% | +$4.06M |
|
885
Kemper
KMPR
$3.33B
| $51.1M | 0.01% |
704,140
-8,887
| -1% | -$644K |
|
886
First Solar
FSLR
$22.5B
| $51M | 0.01% |
1,031,119
-14,533
| -1% | -$719K |
|
887
Spire
SR
$4.53B
| $50.8M | 0.01% |
773,174
+18,777
| +2% | +$1.23M |
|
|
NVTA
888
DELISTED
Invitae Corporation
NVTA
| $50.8M | 0.01% |
1,675,793
+405,117
| +32% | +$12.3M |
|
889
Tradeweb Markets
TW
$24.5B
| $50.6M | 0.01% |
871,910
+318,125
| +57% | +$18.5M |
|
890
Caesars Entertainment
CZR
$5.4B
| $50.6M | 0.01% |
1,262,144
+285,915
| +29% | +$11.5M |
|
|
PLAN
891
DELISTED
Anaplan, Inc.
PLAN
| $50.5M | 0.01% |
1,115,635
+190,256
| +21% | +$8.62M |
|
892
Radian Group
RDN
$4.94B
| $50.4M | 0.01% |
3,249,277
-39,712
| -1% | -$616K |
|
893
NeoGenomics
NEO
$1.09B
| $50.3M | 0.01% |
1,623,673
+122,233
| +8% | +$3.79M |
|
894
Littelfuse
LFUS
$6.6B
| $50.2M | 0.01% |
294,377
+1,481
| +0.5% | +$253K |
|
|
PRSP
895
DELISTED
Perspecta Inc. Common Stock
PRSP
| $50.2M | 0.01% |
2,159,959
+30,465
| +1% | +$708K |
|
896
Nektar Therapeutics
NKTR
$1.06B
| $50M | 0.01% |
143,875
+3,130
| +2% | +$1.09M |
|
897
National Health Investors
NHI
$3.74B
| $49.5M | 0.01% |
815,654
+161,951
| +25% | +$9.83M |
|
898
SouthState Bank Corporation
SSB
$10.4B
| $49.5M | 0.01% |
1,038,385
+545,099
| +111% | +$26M |
|
899
Ziff Davis
ZD
$1.61B
| $49.5M | 0.01% |
899,637
+24,142
| +3% | +$1.33M |
|
900
RBC Bearings
RBC
$12.1B
| $49.5M | 0.01% |
368,982
+14,036
| +4% | +$1.88M |
|